SEC FORM 4
—
Monopar Therapeutics (MNPR)
Acquisition (code M) of 614 shares; price not stated (see filing).
Reporting Person Vu Quan Anh · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 30, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001437749-26-031924 · filed 2026-10-02 · View filing →